I am a
Home I AM A Search Login

Papers of the Week


January 27, 2023


Oncologist


http://www.ncbi.nlm.nih.gov/pubmed/36571770?dopt=Abstract

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors.

Authors

Barlesi F, Isambert N, Felip E, Cho B C, Lee D H, Peguero J, Jerusalem G, Penel N, Saada-Bouzid E, Garrido P, Helwig C, Locke G, Ojalvo LS, Gulley JL
Oncologist. 2022 Dec 26.
PMID: 36571770.

Abstract

Bintrafusp alfa is a first-in-class bifunctional fusion protein composed of the extracellular domain of transforming growth factor beta receptor II (a TGF-β "trap") fused to a human immunoglobulin G1 monoclonal antibody blocking programmed cell death 1 ligand 1 (PD-L1). We report the efficacy and safety in patients with non-small cell lung cancer (NSCLC) that progressed following anti-PD-(L)1 therapy.